Sean Mcclain

Biography

 AbSci has developed a proprietary engineered E. coli expression system that will allow for an easily optimizable and scalable production of soluble recombinant monoclonal antibodies as well as other therapeutic proteins. These therapeutic proteins and antibodies are used in cancer and hormone therapies, as well as autoimmune and blood disorder therapies.

Research Interest

 Protein Chemistry and Life Science